MCD
67
2
PEP
47
-3
ITW
62
-2
EOG
42
-8
ALL
61
-2
ACN
56
13
NKE
46
12
NEM
48
2
FLS
56
-3
PYPL
43
-4
PEG
76
5
ADM
33
-3
BMY
56
3
PNW
66
3
BF.B
43
-7
CNX
80
4
KMI
59
2
CAG
46
10
LEN
55
-9
HIG
68
4
MCD
67
2
PEP
47
-3
ITW
62
-2
EOG
42
-8
ALL
61
-2
ACN
56
13
NKE
46
12
NEM
48
2
FLS
56
-3
PYPL
43
-4
PEG
76
5
ADM
33
-3
BMY
56
3
PNW
66
3
BF.B
43
-7
CNX
80
4
KMI
59
2
CAG
46
10
LEN
55
-9
HIG
68
4
Financhill
Back

Supernus Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
27

SUPN
Supernus Pharmaceuticals

Last Price:
31.81
Seasonality Move:
-10.48%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
27
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $31.83. The Score for SUPN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $31.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 43.66 Sell
Chaikin Money Flow: -233670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.09 - 35.05) Sell
Bollinger Bands (100): (27.02 - 32.74) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.51 Buy
20-day SMA: 33.35 Sell
50-day SMA: 31.99 Sell
200-day SMA: 29.79 Buy
8-day EMA: 32.03 Sell
20-day EMA: 32.58 Sell
50-day EMA: 31.9 Sell
200-day EMA: 30.36 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):